All patients older than age 60 years should not undergo a B-type natriuretic peptide screening test.
Chatterjee
Kanu
K
Chatterjee Center for Cardiac Research, UCSF Division of Cardiology, University of California-San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143-0124, USA. chatterj@medicine.vcsf.edu
D000208:Acute Disease; D000367:Age Factors; D000368:Aged; D002908:Chronic Disease; D004417:Dyspnea / Q000209:etiology; D015577:Geriatric Assessment / Q000379:methods; D006333:Heart Failure / Q000097:blood / Q000145:classification / Q000150:complications / Q000175:diagnosis*; D006801:Humans; D008403:Mass Screening / Q000379:methods* / Q000592:standards; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D018579:Patient Selection; D011379:Prognosis; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
D020097:Natriuretic Peptide, Brain